# Agentic MIDDAY Scan — 2026-08-15

- Account: Robinhood Agentic ••••1041 (`433711041`), cash account, agentic-enabled
- Policy: `playbook/autonomous-policy.md` ACTIVE; no date-specific plan found
- Session state: **Saturday / U.S. equity market closed**. Latest executable-quality data is unavailable; quotes and 5-minute bars are from Friday 2026-08-14. Therefore no order was reviewed or placed.

## Decision

**PAUSE NEW ENTRIES AND EXECUTION; HOLD OPERATIONALLY UNTIL MONDAY PRICE DISCOVERY.** AVGO closed below its prior $407.50 binding invalidation and is the weakest holding; prioritize an exit/rotation review at the next live regular-hours scan. Do not submit a weekend market order against stale/wide off-hours quotes. MA, BAC, and SHOP remain technical holds. No stop was widened and no averaging occurred.

## Broker and kill-switch verification

- Account verified active and agentic-accessible; only account ••••1041 inspected/operated.
- Portfolio value: $335.09; equity value: $302.98; cash/buying power: $32.11; unsettled funds: $0.
- Positions, all fully sellable: AVGO 0.095750 @ $411.28; MA 0.113541 @ $572.48; BAC 1.046363 @ $62.12; SHOP 0.862075 @ $144.09.
- Open-ish equity orders checked separately in states `new`, `queued`, `confirmed`, `unconfirmed`, `partially_filled`: none.
- Orders/fills created on 2026-08-15: none.
- Kill switch: account value is above $10. No 5% daily drawdown evidence from the broker snapshot, but weekend/stale market state blocks execution-quality risk calculation; new trading paused under the uncertainty gate.

## Holdings and management ranking

Friday 2026-08-14 closing data:

1. **SHOP — HOLD, 14/16.** $154.50 after hours / $154.43 regular close; position value ~$133.19, P/L +$8.97 (+7.22%). Daily close $154.32 vs SMA20 $133.61 and SMA50 $122.92; 20d +24.89%, 60d +52.78%; Friday below VWAP $155.10 with only 0.47x normal volume. Q2 revenue $3.583B (+34% YoY), 18% FCF margin and low-30s Q3 revenue-growth outlook support the catalyst; valuation (~104x trailing earnings) and post-gap volatility remain risks. Prior binding stop $141.50; targets $155/$162. Target zone reached but momentum did not provide a live-session exit signal during this closed-market run; reassess for profit protection Monday.
2. **BAC — HOLD, 13/16.** $64.48 after hours / $64.49 close; value ~$67.47, P/L +$2.47 (+3.80%). Above SMA20 $62.61 and SMA50 $59.64; 20d +5.26%, 60d +27.20%; near $65.20 52-week resistance and above VWAP $64.41. Q2 revenue $31.56B, net income $9.07B, NII guidance and trading/deal strength support; XLF closed near flat and rate/credit sensitivity remain risks. Binding stop $61.80; target $64.90. Review profit-taking if $64.90–$65.20 rejects.
3. **MA — HOLD, 13/16.** $569.29; value ~$64.64, P/L -$0.36 (-0.56%). Above SMA20 $559.40 and SMA50 $529.25; 20d +4.73%, 60d +13.93%; Friday held above VWAP $567.93 on 0.83x normal volume. Q2 revenue $9.277B (+14% YoY), adjusted EPS beat, 12% cross-border growth and ~47.3% net margin support quality. Binding stop $560; targets $583.70/$596.
4. **AVGO — EXIT/ROTATE REVIEW NEXT LIVE SESSION, 8/16.** $393.55 after hours / $393.08 close; value ~$37.68, P/L -$1.70 (-4.31%). Friday fell 5.92% from prior close, closed below SMA20 $399.49 but above SMA50 $390.47, below VWAP $395.73, on 1.66x normal volume; 60d momentum is -4.40%. It breached the prior $407.50 binding invalidation and deeper $400.50 thesis level. Fundamentals remain strong (Q2 revenue $22.187B, net income $9.31B, ~42% margin; Sep. 2 earnings catalyst), but the technical thesis is invalidated and sector-relative momentum deteriorated. No weekend order placed because market is closed and displayed off-hours spread was non-executable/stale. Monday priority: exit on live confirmation rather than widen the stop.

## Regime and broad scan

- Regime: **trend/risk-on but rotational**, not risk-off. SPY $776.34 > SMA20 $756.20 > SMA50 $748.93; QQQ $731.07 > SMA20 $704.13 and SMA50 $712.95; IWM set a 52-week high at $305.18. Friday breadth favored small caps while SPY/QQQ slipped ~0.2%/0.14%. XLK remained above SMA20/50 but AVGO-specific weakness was severe; XLF remained near highs.
- Macro/news: softer inflation reduced near-term Fed-hike pressure, while July retail sales softened; oil rose on Persian Gulf shipping risk. Sector research favors financials, health care, industrials and materials; technology is neutral and consumer discretionary least favored.

### Fresh candidate ranking

The Daily Movers list was screened beyond stale watchlists. Most names failed liquidity, price, spread, profitability, or one-day-spike rules.

1. **IMXI — 10/16, WATCH RETEST ONLY.** $14.59 close / $15 after hours, 5.17M shares vs 0.71M 30-day average; profitable (~23.5x PE), but Friday's ~25% gap needs catalyst verification and a retest near $13.70–$14.20. No chase.
2. **ETON — 10/16, WATCH RETEST ONLY.** $58.51 close, 2.32M volume vs 0.62M average and a 52-week high; however, ~43% one-day extension, ~156x PE and pharma catalyst risk demand a consolidation/retest. No chase.
3. **HTFL — 9/16, NO TRADE.** $42.11, 9.91M volume vs 1.44M average and new high, but unprofitable and ~36% gap with no verified catalyst in this scan.
4. **UMAC — 9/16, NO TRADE.** $33.94, 15.96M volume and new high, but development-stage, loss-making, and ~25% one-day extension; no chase.
5. **CAPR — 7/16, NO TRADE.** Highly liquid on Friday but clinical-stage, loss-making, and an extreme reversal/gap with binary biotech risk.

No fresh candidate reached 13/16 or offered a confirmed, materially superior risk-adjusted setup. AVGO remains the likely funding source for a future rotation, but proceeds should stay cash until a candidate confirms.

## Deployment and reserve

- Current invested equity: $302.98 / $335.09 = **90.42% deployed**; cash = **9.58%** of account value.
- No pending-order encumbrance; liquid buying power = $32.11.
- Mechanical 80% of that balance is $25.69 and 20% is $6.42, but the $32.11 is the surviving designated reserve from the prior deployment cycle. Recursively spending 80% would reduce total cash to 1.92% of account value and violate the policy's reserve logic. Therefore **$0 newly deployed; $32.11 reserve retained**.
- Planned open risk using prior stops is roughly AVGO $0 (already breached and pending live exit review), MA $1.05, BAC $2.81, SHOP $2.23 = ~$6.09, near the policy's ~$6 aggregate target; this further blocks a new entry before AVGO is resolved.

## Actions and fills

- Reviews: none.
- Placements/cancellations: none.
- Fills: none.
- Reason: weekend closure and stale/non-executable market state; policy uncertainty gate overrides the activity mandate.
